COGNETIVITY NEUROSCIENCES LTD News

AI-Powered Psychedelic Treatments: Special Status And Next-Gen Contests Winners

As psychedelics and AI travel their own development paths, here are some initiatives looking at ways of enhancing the former with the latter's help. AI-Infused Research Partnerships The Institute of B

BenzingaJun 8, 2023 17:25 ET

Eli Lilly Releases Results On Latest Disease Modifying Therapeutic For Alzheimer's Disease, Highlighting Need For Cognetivity's CognICA Platform

The news highlights the urgent need for more consistent, wide scale detection of the disease at an early stageVancouver, British Columbia--(Newsfile Corp. - May 9, 2023) - Cognetivity Neurosciences Lt

BenzingaMay 9, 2023 09:31 ET

UK-Based Psychedelics Ancillary Business Wraps Up $3M Funding Round

A tech company responsible for creating a clinical testing platform that uses AI and machine learning for the detection of earliest cognitive impairment signs, Cognetivity Neurosciences Ltd. (OTCQB:CG

Benzinga Real-time NewsOct 28, 2022 08:16 ET

Ketamine One Teams Up With Cognetivity Neurosciences To Study PTSD, Depression

Ketamine One, a Canada-based health and wellness company focused on treatments for mental health, is teaming up with Cognetivity Neurosciences (OTC:CGNSF) for a collaborative study on treatments for P

Benzinga Real-time NewsDec 2, 2021 12:36 ET

Press Release: Cognetivity Neurosciences Announces Securities Issuances

Cognetivity Neurosciences Announces Securities Issuances Canada NewsWire VANCOUVER, BC, Nov. 5, 2021 VANCOUVER, BC, Nov. 5, 2021 /CNW/ - The Company has issued 220,000 common shares at

Dow Jones NewswiresNov 5, 2021 14:30 ET

Press Release: Cognetivity Neurosciences Wins Health & Technology Awards and Announces Corporate Update

Cognetivity Neurosciences Wins Health & Technology Awards and Announces Corporate Update Canada NewsWire VANCOUVER, BC, Oct. 13, 2021 Company's technology awarded 'Best use of AI an

Dow Jones NewswiresOct 13, 2021 14:42 ET